公开(公告)号：US20070220341A1

公开(公告)日：2007-09-20

申请号：US11363725

申请日：2006-02-28

Applicant: Laura Apostoloiu ,  Xin Chen ,  R. Harvey ,  Young Lee ,  Kyle Robeson

Inventor： Laura Apostoloiu ,  Xin Chen ,  R. Harvey ,  Young Lee ,  Kyle Robeson

IPC: G06F11/00

CPC classification number: G06F11/3684 ,  G06F11/3664

Abstract: Embodiments of the present invention address deficiencies of the art in respect to software test automation and provide a method, system and apparatus for a reusable software testing framework. In one embodiment of the invention, an automated application test data processing system can include a reusable test automation framework. The system further can include a test task generator and a scenario generator coupled to one another and to the framework. In this regard, the test task generator can be configured to generate uniform logic for performing testing tasks, while the scenario generator can be configured to arrange testing tasks for a complete test scenario. Finally, a collaborative testing environment can be provided through which multiple users can interact with the scenario generator and test task generator to produce test cases of different test scenarios

Abstract translation: 本发明的实施例解决了本领域在软件测试自动化方面的缺陷，并且提供了一种用于可重复使用的软件测试框架的方法，系统和装置。 在本发明的一个实施例中，自动应用测试数据处理系统可以包括可重用的测试自动化框架。 该系统还可以包括测试任务生成器和彼此耦合到框架的脚本生成器。 在这方面，测试任务生成器可以配置为生成用于执行测试任务的统一逻辑，而脚本生成器可以配置为为完整测试场景安排测试任务。 最后，可以提供协作测试环境，通过该环境，多个用户可以与脚本生成器和测试任务生成器进行交互，以生成不同测试场景的测试用例

公开(公告)号：US20070185314A1

公开(公告)日：2007-08-09

申请号：US11711935

申请日：2007-02-28

Applicant: Bonnie Bassler ,  Stephan Schauder ,  Xin Chen ,  Frederick Hughson ,  Stephen Cooper

Inventor： Bonnie Bassler ,  Stephan Schauder ,  Xin Chen ,  Frederick Hughson ,  Stephen Cooper

IPC: C07K14/195 ,  G06F19/00

CPC classification number: C07K14/28 ,  A61K38/164 ,  A61K47/62 ,  C07K2299/00 ,  Y02A90/26

Abstract: A crystal comprising LuxP is obtained, and a binding site for autoinducer-2 (AI-2) identified. The X-ray crystallographic data for LuxP and a LuxP-AI-2 complex is determined and used in a drug discovery method. Pharmaceutical compositions comprising ligands identified by such drug discovery methods are used to treat bacterial infections.

Abstract translation: 获得包含LuxP的晶体，并鉴定自体诱导剂-2（AI-2）的结合位点。 确定LuxP和LuxP-AI-2复合物的X射线晶体学数据，并用于药物发现方法。 包含通过这种药物发现方法鉴定的配体的药物组合物用于治疗细菌感染。

公开(公告)号：US20070073082A1

公开(公告)日：2007-03-29

申请号：US11525201

申请日：2006-09-20

Applicant: Peng Cheng ,  Jingyuan Ma ,  Xin Chen ,  Yan Zhu ,  Zuchun Zhao

Inventor： Peng Cheng ,  Jingyuan Ma ,  Xin Chen ,  Yan Zhu ,  Zuchun Zhao

IPC: C07C59/88

CPC classification number: C07C233/18 ,  C07B57/00 ,  C07C51/487 ,  C07C231/14 ,  C07C59/88

Abstract: The present invention provides a methods and compounds for producing an enantiomerically enriched α-(phenoxy)phenylacetic acid compound of the formula: from a mixture of its enantiomers, where R1 is alkyl or haloalkyl and X is halide.

Abstract translation: 本发明提供用于制备下式的对映异构体富集的α-（苯氧基）苯乙酸化合物的方法和化合物：其对映异构体的混合物，其中R 1是烷基或卤代烷基，X是卤素 。

公开(公告)号：US20070021386A1

公开(公告)日：2007-01-25

申请号：US11511163

申请日：2006-08-28

Applicant: Adnan Mjalli ,  Robert Andrews ,  Ramesh Gopalaswamy ,  Anitha Hari ,  Kwasi Avor ,  Ghassan Qabaja ,  Xiao-Chuan Guo ,  Suparna Gupta ,  David Jones ,  Xin Chen

Inventor： Adnan Mjalli ,  Robert Andrews ,  Ramesh Gopalaswamy ,  Anitha Hari ,  Kwasi Avor ,  Ghassan Qabaja ,  Xiao-Chuan Guo ,  Suparna Gupta ,  David Jones ,  Xin Chen

IPC: A61K31/695 ,  A61K31/4172

CPC classification number: C07D233/64 ,  C07D235/08 ,  C07D235/12 ,  C07D235/14 ,  C07D235/18 ,  C07D235/30 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D403/14 ,  C07D405/04 ,  C07D405/12 ,  C07D413/12 ,  C07D453/02

Abstract: This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, β-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis.

Abstract translation: 本发明提供某些化合物，其制备方法，包含该化合物的药物组合物及其在治疗人或动物疾病中的用途。 本发明的化合物可用作晚期糖基化终产物（RAGE）的受体与其配体如晚期糖基化终产物（AGE），S100 /钙粒蛋白/ EN-RAGE，β-淀粉样蛋白和两性蛋白之间相互作用的调节剂 ，以及由RAGE引起的人类疾病的管理，治疗，控制或辅助治疗。 这些疾病或疾病状态包括急性和慢性炎症，糖尿病晚期并发症的发展，例如血管通透性增加，肾病，动脉粥样硬化和视网膜病变，阿尔茨海默病的发展，勃起功能障碍和肿瘤侵袭和转移。

公开(公告)号：US20060241262A1

公开(公告)日：2006-10-26

申请号：US11472077

申请日：2006-06-21

Applicant: Huey Wu ,  Charles Martin ,  Xin Chen

Inventor： Huey Wu ,  Charles Martin ,  Xin Chen

IPC: C08F214/18 ,  C08F16/24

CPC classification number: H01M8/1025 ,  C08F216/1408 ,  H01M4/8605 ,  H01M8/0289 ,  H01M8/1004 ,  H01M8/1039 ,  H01M8/1072 ,  H01M2300/0082 ,  H01M2300/0094 ,  Y02P70/56

Abstract: An ionomer and a process for forming the ionomer such that the ionomer has (1) low equivalent weight (below 950, preferably between 625 and 850, and most preferably between 675 and 800) and (2) high conductivity (greater than 0.13 S/cm). In another embodiment, the invention is an ionomer having (1) low equivalent weight (below 950, preferably between 625 and 850, and most preferably between 675 and 800) and (2) acceptably low hydration (less than about 120 weight percent). These ionomers are capable of being processed into thin film and are extremely well-suited for low humidity or high temperature fuel cell applications.

公开(公告)号：US20060241261A1

公开(公告)日：2006-10-26

申请号：US11471759

申请日：2006-06-21

Applicant: Huey Wu ,  Charles Martin ,  Xin Chen

Inventor： Huey Wu ,  Charles Martin ,  Xin Chen

IPC: C08F216/12

CPC classification number: H01M8/1025 ,  C08F216/1408 ,  H01M4/8605 ,  H01M8/0289 ,  H01M8/1004 ,  H01M8/1039 ,  H01M8/1072 ,  H01M2300/0082 ,  H01M2300/0094 ,  Y02P70/56

Abstract: An ionomer and a process for forming the ionomer such that the ionomer has (1) low equivalent weight (below 950, preferably between 625 and 850, and most preferably between 675 and 800) and (2) high conductivity (greater than 0.13 S/cm). In another embodiment, the invention is an ionomer having (1) low equivalent weight (below 950, preferably between 625 and 850, and most preferably between 675 and 800) and (2) acceptably low hydration (less than about 120 weight percent). These ionomers are capable of being processed into thin film and are extremely well-suited for low humidity or high temperature fuel cell applications.

公开(公告)号：US20060135609A1

公开(公告)日：2006-06-22

申请号：US11255478

申请日：2005-10-21

Applicant: Eric Toone ,  David Epstein ,  Pratap Challa ,  Phillip Snyder ,  Xin Chen ,  Mitchell deLong

Inventor： Eric Toone ,  David Epstein ,  Pratap Challa ,  Phillip Snyder ,  Xin Chen ,  Mitchell deLong

IPC: A61K31/225

CPC classification number: A61K31/225 ,  A61K31/712 ,  C07C69/712 ,  C07C69/738 ,  C07H13/04

Abstract: The present invention relates generally to ophthamological drugs. More specifically, the inventon relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same in treating conditions associated with elevated intraocular pressure, particularly, glaucoma.

Abstract translation: 本发明一般涉及眼科药物。 更具体地，本发明涉及一种改变（衍生化）眼科药物以增加其穿透角膜的方法。 本发明还涉及根据本发明方法修饰（衍生化）的药物，以及在治疗与眼内压升高相关的病症，特别是青光眼中的用途。

公开(公告)号：US20060123470A1

公开(公告)日：2006-06-08

申请号：US11252087

申请日：2005-10-18

Applicant: Xin Chen

Inventor： Xin Chen

IPC: H04L9/32

CPC classification number: H04L63/08 ,  H04L63/164 ,  H04W4/00 ,  H04W8/26 ,  H04W12/06 ,  H04W12/08 ,  H04W76/10

Abstract: A method of user authorization for services in a wireless communications network including the steps of: establishing a connection between user equipment and an authorization server of the network; the user equipment providing user identification to the authorization server; the authorization server retrieving authorization data based on the user identification as to a service available to that user; the authorization server returning authorization to the user equipment for a service indicated by the authorization data; and the user equipment establishing a communication path to the service using the authorization

Abstract translation: 一种对无线通信网络中的业务进行用户授权的方法，包括以下步骤：建立用户设备与网络授权服务器之间的连接; 所述用户设备向所述授权服务器提供用户标识; 所述授权服务器基于所述用户可用的服务的用户标识来检索授权数据; 所述授权服务器向所述用户设备返回由所述授权数据指示的服务的授权; 并且用户设备使用授权建立到服务的通信路径

公开(公告)号：US20060088262A1

公开(公告)日：2006-04-27

申请号：US10971319

申请日：2004-10-22

Applicant: George Berkey ,  Xin Chen ,  Joohyun Koh ,  Ming-Jun Li ,  Daniel Nolan ,  Donnell Walton ,  Ji Wang ,  Luis Zenteno

Inventor： George Berkey ,  Xin Chen ,  Joohyun Koh ,  Ming-Jun Li ,  Daniel Nolan ,  Donnell Walton ,  Ji Wang ,  Luis Zenteno

IPC: G02B6/032

CPC classification number: H01S3/06716 ,  C03B37/01234 ,  C03B37/0124 ,  C03B37/01413 ,  C03B37/01446 ,  C03B2201/12 ,  C03B2201/14 ,  C03B2201/28 ,  C03B2201/31 ,  C03B2201/36 ,  C03B2203/12 ,  C03B2203/14 ,  C03B2203/23 ,  C03B2205/10 ,  C03B2207/90 ,  G02B6/023 ,  G02B6/02338 ,  G02B6/02366 ,  G02B6/024 ,  G02B6/03611 ,  G02B6/0365 ,  G02B6/03666 ,  G02B2006/1208 ,  H01S3/06729 ,  H01S3/1618 ,  H01S3/1695

Abstract: An optical fiber including: (i) a silica based, rare earth doped core having a first index of refraction n1; (ii) a silica based inner cladding surrounding the core and having a second index of refraction n2, such that n1>n2, said inner cladding having a plurality of air holes extending longitudinally through the length of said optical fiber; (iii) a silica based outer cladding surrounding said inner cladding and having a third index of refraction n3, such that n2>n3, wherein said optical fiber supports a single polarization mode within the operating wavelength range.

Abstract translation: 一种光纤，包括：（i）具有第一折射率n 1的二氧化硅基稀土掺杂的芯; （ii）围绕所述芯并且具有第二折射率n 2 2的基于二氧化硅的内包层，使得n 1，N 2， 所述内包层具有沿所述光纤的长度纵向延伸的多个气孔; （iii）围绕所述内包层并具有第三折射率n 3 3的基于二氧化硅的外包层，使得n 2 N 3 N 3 其中所述光纤在工作波长范围内支持单一偏振模式。

公开(公告)号：US20060085518A1

公开(公告)日：2006-04-20

申请号：US10965597

申请日：2004-10-14

Applicant: Robert Blackmore ,  Xin Chen ,  Chulho Kim ,  Rajeev Sivaram ,  Richard Treumann ,  Hanhong Xue

Inventor： Robert Blackmore ,  Xin Chen ,  Chulho Kim ,  Rajeev Sivaram ,  Richard Treumann ,  Hanhong Xue

IPC: G06F15/16

CPC classification number: H04L67/10 ,  H04L69/06 ,  H04L69/328

Abstract: A method and system for transferring noncontiguous messages group including assembling a set of data into a series of transmission packets, packaging a description of the layout of the transmission packets into description packets and then places each description packet into a local buffer while maintaining a count of the number of description packets, transfers each description packet into a transmit buffer for transmission to at least one receiving node, identifies the data packets, and forwards each data packet to the transmit buffer for transmission to the at least one receiving node. The receiving node receives the transmission packets, identifies each packet as a description packet or data packet, places the description packets in a local buffer for storage until the description is complete, places each description packet into a user data buffer, stores data packets in a local queue until the description is complete, then transfers the data packets to the user buffer.

Abstract translation: 一种用于传送不连续消息组的方法和系统，包括将一组数据组合成一系列传输分组，将传输分组的布局的描述打包成描述分组，然后将每个描述分组放置到本地缓冲器中，同时保持计数 描述分组的数量将每个描述分组传送到用于发送到至少一个接收节点的发送缓冲器，识别数据分组，并将每个数据分组转发到发送缓冲器以传输到至少一个接收节点。 接收节点接收传输分组，将每个分组标识为描述分组或数据分组，将描述分组置于本地缓冲区中进行存储，直到描述完成，将每个描述分组放入用户数据缓冲区，将数据分组存储在 本地队列直到描述完成，然后将数据包传送到用户缓冲区。